Delsym and Nasacort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Delsym (dextromethorphan polistirex) and Nasacort (triamcinolone acetonide). Common drug interactions include nasopharyngitis among females and autoimmune disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Delsym and Nasacort. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Delsym?

Delsym has active ingredients of dextromethorphan polistirex. It is often used in cough. eHealthMe is studying from 5,033 Delsym users. Check the latest studies of Delsym.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

On Jul, 26, 2026

18 people who take Delsym and Nasacort together, and have interactions are studied.

What are the common drug interactions of Delsym and Nasacort, by gender? *:

female:

Nasopharyngitis (inflammation of the nasopharynx)
Abdominal discomfort
Anxiety
Asthma
Blood potassium decreased
Choking sensation (feeling of obstruction in respiratory system)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Gait disturbance
Hypersensitivity

male:

Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Confusional state
Anosmia (partial or complete loss of the sense of smell)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Renal failure (kidney dysfunction)
Fatigue (feeling of tiredness)

What are the common drug interactions of Delsym and Nasacort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fatigue (feeling of tiredness)
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Confusional state
Fear
Stress
Abdominal discomfort
Anxiety
Asthma
Blood potassium decreased
Choking sensation (feeling of obstruction in respiratory system)

40-49:

Suicidal ideation
Anosmia (partial or complete loss of the sense of smell)
Depression
Mood altered (changes in mood)

50-59:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Renal failure (kidney dysfunction)

60+:

Ageusia (loss of taste functions of the tongue)

What are the existing conditions these people have? *

Drowsiness: 3 people, 16.67%
Osteoporosis (bones weak and more likely to break): 3 people, 16.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 16.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 16.67%
Stress And Anxiety: 3 people, 16.67%
Growth Hormone Deficiency: 3 people, 16.67%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 2 people, 11.11%
Hiv Infection: 2 people, 11.11%
Upper-Airway Cough Syndrome: 1 person, 5.56%
Asthma: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Delsym and Nasacort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously